ViewsML joins the Debiopharm Innovation Fund portfolio
Carevive acquired by Health Catalyst
WhiteLab Genomics expands to the US
Efficacy of Mika: A Digital Therapeutic for distress reduction in cancer patients
Risklick joins Debiopharm Innovation Fund Portfolio
Yonalink Partners with AI4LUNGS
BC Platforms and NTT Group announce exclusive collaboration
Genialis uses machine learning to personalize cancer treatment outcomes
New Genialis RNA biomarker accurately predicts KRAS outcomes in lung cancer patients